BGMVSLABT• 12 Months (Normalized)
BGM vs LABT (BGM Group Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BGM Performance $9.34
-8.21%
BGM Group Ltd.
Normalized Baseline0.00%
LABT Performance $0.93
-98.92%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BGM LEADS
+90.71 pts
BGM outperforming by 90.71 percentage points
BGMLABT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BGM LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | BGM Price | BGM Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $9.34 | -8.21% | $0.93 | -98.92% | +90.71% |
| Sep 29, 2026 | $0.26 | -97.46% | $0.99 | -98.86% | +1.40% |
| Sep 28, 2026 | $0.24 | -97.60% | $1.15 | -98.67% | +1.07% |
| Sep 25, 2026 | $0.24 | -97.64% | $1.67 | -98.07% | +0.43% |
| Sep 24, 2026 | $0.25 | -97.55% | $1.83 | -97.88% | +0.33% |
| Sep 23, 2026 | $0.26 | -97.49% | $1.78 | -97.94% | +0.45% |
| Sep 22, 2026 | $0.26 | -97.49% | $1.99 | -97.70% | +0.21% |
| Sep 21, 2026 | $0.26 | -97.48% | $2.05 | -97.63% | +0.15% |
| Sep 18, 2026 | $0.25 | -97.53% | $1.99 | -97.70% | +0.17% |
| Sep 17, 2026 | $0.26 | -97.45% | $1.86 | -97.85% | +0.40% |
| Sep 16, 2026 | $0.26 | -97.46% | $2.09 | -97.58% | +0.12% |
| Sep 15, 2026 | $0.25 | -97.57% | $2.17 | -97.49% | -0.08% |
| Sep 14, 2026 | $0.26 | -97.49% | $2.12 | -97.55% | +0.06% |
| Sep 11, 2026 | $0.26 | -97.42% | $2.22 | -97.43% | +0.01% |
| Sep 10, 2026 | $0.28 | -97.29% | $2.05 | -97.63% | +0.34% |
Page 1 of 17